OCTA-guided navigated laser therapy for advanced macula neovascularization secondary to age related macular degeneration

Abstract

Introduction:

To evaluate the effects of the Navilas system guided by optical coherence tomography angiography for advanced macular neovascularization (MNV) secondary to age-related macular degeneration (AMD).

Methods:

Prospective case-series including nine eyes presenting with advanced MNV with persistence of exudative signs, no longer responding to anti-VEGF therapy, best-corrected visual acuity at least of 1.3 logMar. All patients were treated with Navilas guided by overlaid optical coherence tomography angiography (OCTA) images at the site of branching large neovascular trunks.

Results:

Occlusion of large neovascular trunks successfully occurred in all nine included patients. OCTA analysis revealed, at 1 month follow up, MNV total area decreasing from 6.2 ± 3.1 to 2.6 ± 3.4 mm². At 6 months follow up, mean MNV area was 3.3 ± 3.4 mm² (p = 0.008).

Conclusion:

This preliminary study showed that Navilas treatment guided by OCTA may represent an attractive therapeutic option in advanced neovascular lesions secondary to AMD.

Keywords

Get full access to this article

View all access options for this article.

References

Bressler

Age-related macular degeneration is the leading cause of blindness. JAMA 2004; 291(15): 1900–1901.

Bora

Sohn

Cruz

, et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 2005; 174(1): 491–497.

Ferris

III Fine

Hyman

Age related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102: 1640–1642.

Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994; 112: 480–488.

Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991; 109: 1242–1257.

Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991; 109: 1220–1231.

Orth

Rosculet

De Bustros

Foveal sparing photocoagulation for exudative age-related macular degeneration. Retina 1994; 14: 153–159.

Tornambe

Poliner

Hovey

, et al. Scatter macular photocoagulation for subfoveal neovascular membranes in age-related macular degeneration. A pilot study. Retina 1992; 12: 305–314.

Coscas

Soubrane

Ramahefasolo

, et al. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991; 109: 1258–1265.

10.

Bressler

Maguire

Murphy

, et al. Macular scatter (“Grid”) laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Arch Ophthalmol 1996; 114: 1456–1464.

11.

Arnold

Algan

Soubrane

, et al. Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1997; 235: 208–216.

12.

Coscas

Stanescu

Coscas

, et al. Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration. J Fr Ophtalmol 2003; 26(6): 602–608.

13.

Jia

Tan

Tokayer

, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012; 20(4): 4710–4725.

14.

Miere

Semoun

Cohen

, et al. Optical coherence tomography angiography features of subretinal fibrosis in age-related macular degeneration. Retina Phila Pa 2015; 35(11): 2275–2284.

15.

Kernt

Cheuteu

Vounotrypidis

, et al. Focal and panretinal photocoagulation with a navigated laser (NAVILAS®). Acta Ophthalmol (Copenh) 2011; 89(8): e662–e664.

16.

Neubauer

Langer

Liegl

, et al. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol Auckl NZ 2013; 7: 121–128.

17.

Alshahrani

Ghazi

NG.

Navigated laser (navilas) therapy for choroidal neovascular and hyperpermeability pathologies. Retin Cases Brief Rep 2015; 9(2): 117–120.

18.

Zhang

Chen

C-L

Chu

, et al. Automated quantitation of choroidal neovascularization: a comparison study between spectral-domain and swept-source OCT angiograms. Invest Ophthalmol Vis Sci 2017; 58(3): 1506–1513.

19.

Miller

Roisman

Zhang

, et al. Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization. Invest Ophthalmol Vis Sci 2017; 58(3): 1499–1505.

20.

Copete

Flores-Moreno

Montero

, et al. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol 2014; 98(3): 334–338.

21.

Kozak

Oster

Cortes

, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology 2011; 118(6): 1119–1124.

22.

Liegl

Langer

Seidensticker

, et al. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One 2014; 9(12): e113981.

23.

Kernt

Cheuteu

Cserhati

, et al. Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas). Clin Ophthalmol Auckl NZ 2012; 6: 289–296.

24.

Shiraga

Ojima

Matsuo

, et al. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 1998; 105(4): 662–669.

25.

Staurenghi

Orzalesi

La Capria

, et al. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 1998; 105(12): 2297–2305.

26.

Chamberlin

Bressler

, et al. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation study group. Ophthalmology 1989; 96(10): 1526–1534.

27.

Flower

RW.

Optimizing treatment of choroidal neovascularization feeder vessels associated with age-related macular degeneration. Am J Ophthalmol 2002; 134(2): 228–239.

28.

Da Costa

Rocha

Calucci

, et al. Neovascular ingrowth site prothrommbosis in choroidal neovascluarization associated with retinal pigment epithelial detachment. Graefes Arch Clin Exp Ophtalmol 2003; 241(3): 245–250.

29.

Querques

Parravano

Borrelli

, et al. Anatomical and functional changes in neovascular AMD in remission: comparison of fibrocellular and fibrovascular phenotypes. Br J Ophthalmol. Epub ahead of print 18 Apr 2019. DOI: 10.1136/bjophthalmol-2018-13685.

30.

Heier

Brown

Chong

, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 2012; 119(12): 2537–2548.

31.

Brown

Michels

Kaiser

, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009; 116(1): 57–65.e5.

32.

Rosenfeld

Brown

Heier

, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1419–1431.

33.

Kodjikian

Souied

Mimoun

, et al. Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the GEFAL noninferiority randomized trial. Ophthalmology 2013; 120(11): 2300–2309.

34.

Ozkiris

Anti-VEGF agents for age-related macular degeneration. Expert Opin Ther Pat 2010; 20(1): 103–118.